- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-alcoholic Fatty Liver Disease (NAFLD) in New Zealand
Total 279 results
-
Arrowhead PharmaceuticalsCompletedNon-alcoholic SteatohepatitisNew Zealand
-
PfizerCompletedNon-Alcoholic Fatty Liver Disease (NAFLD)United States
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruiting
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States, New Zealand
-
Northwell HealthWithdrawnNon-alcoholic Fatty Liver Disease (NAFLD)United States
-
National Institute of Diabetes and Digestive and...Johns Hopkins UniversityTerminatedNAFLD - Nonalcoholic Fatty Liver DiseaseUnited States
-
National Institute of Diabetes and Digestive and...National Cancer Institute (NCI); National Center for Advancing Translational... and other collaboratorsCompletedNonalcoholic Fatty Liver Disease (NAFLD)United States
-
Akero Therapeutics, IncRecruitingNASH/MASH | NAFLD/MASLDUnited States, Canada, Puerto Rico, Australia, India
-
Yale UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Recruiting
-
RWTH Aachen UniversityRecruiting
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis NASHUnited Kingdom, United States, Australia, New Zealand, Switzerland, Jordan, Georgia, Puerto Rico
-
Merck Sharp & Dohme LLCRecruitingNon-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Fatty Liver, NonalcoholicCanada, United States, Puerto Rico, Japan, Korea, Republic of, Taiwan, Spain, Israel, Chile, France, Italy, Hungary, Switzerland, Belgium, China, Singapore, Czechia, Portugal, Austria, United Kingdom, Thailand, Hong Kong, Turkey, Colo...
-
Enanta Pharmaceuticals, IncICON Clinical Research; Triangle BiostatisticsCompletedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, New Zealand, Canada, France, Puerto Rico
-
Northwell HealthCompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
Weill Medical College of Cornell UniversityRecruitingNon-Alcoholic Fatty Liver DiseaseUnited States
-
Columbia UniversityGlaxoSmithKlineCompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
GenMont Biotech IncorporationFu Jen Catholic University HospitalRecruitingNon-Alcoholic Fatty Liver DiseaseTaiwan
-
Institute of Liver and Biliary Sciences, IndiaWithdrawnNon Alcoholic SteatohepatitisIndia
-
Meridian Bioscience, Inc.CompletedNon-Alcoholic SteatohepatitisUnited States, France, Belgium, United Kingdom
-
Institute of Liver and Biliary Sciences, IndiaCompletedNon Alcoholic SteatohepatitisIndia
-
GenfitTerminatedNon Alcoholic SteatohepatitisUnited States
-
Viking Therapeutics, Inc.CompletedNAFLD | HyperlipidemiaUnited States
-
Hepanova Inc.UnknownNon-Alcoholic Steatohepatitis (NASH)United States
-
Hepion Pharmaceuticals, Inc.Active, not recruitingNAFLD | Nonalcoholic Steatohepatitis (NASH) | Fibrosis, LiverUnited States, France, Mexico
-
Fu Jen Catholic University HospitalEnrolling by invitationNon-alcoholic Fatty Liver DiseaseTaiwan
-
Weill Medical College of Cornell UniversityYMCAActive, not recruitingLiver Diseases | Weight Loss | NAFLDUnited States
-
Institute of Liver and Biliary Sciences, IndiaUnknownNon Alcoholic SteatohepatitisIndia
-
Bristol-Myers SquibbCompletedNonalcoholic Steatohepatitis | Liver Fibrosis | Nonalcoholic Fatty Liver Disease (NAFLD)United States, Japan
-
NeuroBo Pharmaceuticals Inc.RecruitingNON-ALCOHOLIC STEATOHEPATITISUnited States
-
PfizerCompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisUnited States
-
Institute of Liver and Biliary Sciences, IndiaWithdrawnNon Alcoholic SteatohepatitisIndia
-
Immuron Ltd.CompletedNon-alcoholic Steatohepatitis (NASH)United States, Australia, Israel
-
Enanta Pharmaceuticals, IncTerminatedNon-Alcoholic SteatohepatitisUnited States, Canada, Puerto Rico, United Kingdom, Argentina, Germany
-
Mochida Pharmaceutical Company, Ltd.CompletedSteatohepatitisUnited States, Puerto Rico
-
Madrigal Pharmaceuticals, Inc.UnknownNon-alcoholic SteatohepatitisUnited States
-
Institute of Liver and Biliary Sciences, IndiaUnknownNon-Alcoholic Fatty Liver DiseaseIndia
-
Rockefeller UniversityNational Institutes of Health (NIH); Weill Medical College of Cornell UniversityCompletedObesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
PfizerCompletedLiver Fibrosis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Bristol-Myers SquibbCompletedNonalcoholic Steatohepatitis | Liver Fibrosis | Nonalcoholic Fatty Liver Disease (NAFLD) | Hepatic CirrhosisUnited States, Japan
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Institute of Liver and Biliary Sciences, IndiaCompletedNon-alcoholic SteatohepatitisIndia
-
Rivus Pharmaceuticals, Inc.RecruitingFatty Liver | Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis (NASH)Belgium, Germany, Taiwan, Austria, United States, Spain, Korea, Republic of, Argentina, Australia, Italy, Japan, Singapore, Netherlands, Slovakia, France, Canada, India
-
Novo Nordisk A/SActive, not recruitingNon-alcoholic SteatohepatitisSpain, Denmark, Taiwan, Korea, Republic of, Australia, Canada, India, Singapore, United States, Turkey, Poland, Italy, Belgium, Puerto Rico, United Kingdom, Malaysia, Germany, Portugal, Bulgaria, Czechia, France, Greece, Japan, Russian...
-
Intercept PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, Finland, France, Spain, United Kingdom, Israel, Austria, Italy, Denmark, Germany, Belgium, Switzerland, Puerto Rico, Poland, Australia, Sweden, Serbia, New Zealand, Canada, Hungary, Portugal
-
Fibronostics USA, IncCompletedNon-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Liver Inflammation | Liver Fibroses | Liver SteatosesUnited States
-
Boehringer IngelheimCompletedNon-alcoholic Steatohepatitis (NASH)United States, Spain, Korea, Republic of, United Kingdom, Australia, Canada, Singapore, Germany, Italy, Malaysia, China, France, Japan, Taiwan, Netherlands, Austria, Israel, New Zealand, Poland, Hong Kong, Belgium, Czechia, Greece, Hu... and more
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisUnited States, France
-
PfizerCompletedNon-alcoholic Fatty Liver DiseaseUnited States
-
GenfitPremier Research Group plc; NaturalphaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Belgium, France, Germany, Italy, Netherlands, Romania, Spain, United Kingdom